CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroi... CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0957 | -11.7683226758 | 0.8132 | 0.82 | 0.6859 | 219590 | 0.74345324 | CS |
| 4 | -1.1025 | -60.5769230769 | 1.82 | 2.89 | 0.6859 | 2845715 | 1.03220066 | CS |
| 12 | 0.2509 | 53.7719674239 | 0.4666 | 11 | 0.37 | 1017781 | 1.34435195 | CS |
| 26 | -1.0625 | -59.691011236 | 1.78 | 11 | 0.37 | 799245 | 1.25267709 | CS |
| 52 | -1.7925 | -71.4143426295 | 2.51 | 11 | 0.37 | 1842615 | 0.99061709 | CS |
| 156 | -11.8825 | -94.3055555556 | 12.6 | 12.89 | 0.04 | 7930789 | 0.3292311 | CS |
| 260 | -11.8825 | -94.3055555556 | 12.6 | 12.89 | 0.04 | 7930789 | 0.3292311 | CS |
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
WestTexas
5月前
shurtha2000
6月前
tw0122
6月前
tw0122
6月前
WestTexas
8月前
hondaboost
8月前
ironhammer
8月前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。